Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Beyond language barriers: DivvyHQ partners with translation tech firm for greater global reach
A newly announced partnership provides DivvyHQ an expanded toolset to open the doors to a global market — translating and delivering any type of marketing-related content across any device, channel or language, said Brock Stechman. “We’ve been working so hard over the past few years to really build this company from the ground up,” said…
Techweek dedicating Oct. 10 afternoon programming to diversity in KC business culture
A first-time programming track dedicated to diversity and inclusion issues is an intentional effort by Techweek Kansas City organizers to open a needed conversation about true representation in the city’s business culture, said Drew Solomon. The mid-point of the Oct. 8-12 Techweek KC event series is expected to feature an afternoon of panel discussions and…
‘Millennial’ isn’t a curse word — it’s a critical marketing tool, says Social Apex Media
Social Apex Media is designed to feed the creativity of hungry millennial entrepreneurs who don’t fit into the corporate culture of many other marketing agencies, said Brandon Priest. “We’re building Social Apex on the backs of entrepreneurs. That means instead of employees who feel like, ‘OK, I just got to work 9 to 5 every…
ProfessionalChats founders on high growth: Don’t reinvent the wheel, just make it better
Entrepreneurship isn’t like Shark Tank, said the co-founders of rapidly expanding Kansas City startup ProfessionalChats. “I think people get confused in the Kansas City entrepreneurship community and they think they need to have an original idea that nobody’s ever done before and they need funding,” said Scott Hansen, co-founder, and CEO. Outside funding doesn’t necessarily…